The Financial Supervisory Commission (FSC) has fined China Life Insurance Co (中國人壽) NT$1.5 million (US$48,228) over breaches of the Insurance Act (保險法), as the insurer failed to determine that clients had insured employees without their consent, the agency said yesterday.
Taipei-based China Life sold three interest-sensitive annuity policies to one corporate client, which claimed it bought the products as part of retirement plans for employees, Insurance Bureau Deputy Director-General Chang Yu-hui (張玉煇) told a news conference.
However, the client failed to confirm with its employees if they agreed to be insured and did not ask the policyholders to submit documents regarding employee benefits, contravening regulations governing business solicitation, policy underwriting and claim adjustment by insurance enterprises, Chang said.
Insurance companies should check the holder’s purpose for the policy and whether those to be insured have given their consent before the purchase, she said.
China Life also sold three savings insurance policies to another two corporate clients, which said that they wanted to insure important employees to avoid losses if they were hurt in an accident, Chang said.
“The clients’ claims were not true. They should have purchased protection policies, such as injury or life insurance, rather than policies linked with wealth management, but China Life failed to detect the discrepancy,” Chang said.
China Life was fined NT$600,000 for the sales to the three companies.
Usually, if companies offer retirement savings, group annuities are used as an incentive to retain employees, Chang said.
After group annuities were approved by the regulator in June 2016, six life insurers had sold such products to 162 companies as of the end of May, with cumulative premiums totaling NT$1.13 billion, the commission said.
China Life was fined another NT$900,000 over breaches of regulations governing transactions with interested parties, Chang said.
China Life let a director attend a board meeting, despite the director having a conflict of interest — an issue that was discussed at the meeting — she said.
China Life said it has reviewed its marketing program and would make adjustments, China Life president Stephanie Hwang (黃淑芬) said in a regulatory filing with the Taiwan Stock Exchange.
Zhang Yazhou was sitting in the passenger seat of her Tesla Model 3 when she said she heard her father’s panicked voice: The brakes do not work. Approaching a red light, her father swerved around two cars before plowing into a sport utility vehicle and a sedan, and crashing into a large concrete barrier. Stunned, Zhang gazed at the deflating airbag in front of her. She could never have imagined what was to come: Tesla Inc sued her for defamation for complaining publicly about the vehicles brakes — and won. A Chinese court ordered Zhang to pay more than US$23,000 in
‘LEGACY CHIPS’: Chinese companies have dramatically increased mature chip production capacity, but the West’s drive for secure supply chains offers a lifeline for Taiwan When Powerchip Technology Corp (力晶科技) entered a deal with the eastern Chinese city of Hefei in 2015 to set up a new chip foundry, it hoped the move would help provide better access to the promising Chinese market. However, nine years later, that Chinese foundry, Nexchip Semiconductor Corp (合晶集成), has become one of its biggest rivals in the legacy chip space, leveraging steep discounts after Beijing’s localization call forced Powerchip to give up the once-lucrative business making integrated circuits for Chinese flat panels. Nexchip is among Chinese foundries quickly winning market share in the crucial US$56.3 billion industry of so-called legacy
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday held its first board of directors meeting in the US, at which it did not unveil any new US investments despite mounting tariff threats from US President Donald Trump. Trump has threatened to impose 100 percent tariffs on Taiwan-made chips, prompting market speculation that TSMC might consider boosting its chip capacity in the US or ramping up production of advanced chips such as those using a 2-nanometer technology process at its Arizona fabs ahead of schedule. Speculation also swirled that the chipmaker might consider building its own advanced packaging capacity in the US as part
‘NO DISRUPTION’: A US trade association said that it was ready to work with the US administration to streamline the program’s requirements and achieve shared goals The White House is seeking to renegotiate US CHIPS and Science Act awards and has signaled delays to some upcoming semiconductor disbursements, two sources familiar with the matter told reporters. The people, along with a third source, said that the new US administration is reviewing the projects awarded under the 2022 law, meant to boost US domestic semiconductor output with US$39 billion in subsidies. Washington plans to renegotiate some of the deals after assessing and changing current requirements, the sources said. The extent of the possible changes and how they would affect agreements already finalized was not immediately clear. It was not known